Trial Outcomes & Findings for Phendimetrazine and Cocaine (NCT NCT02233647)

NCT ID: NCT02233647

Last Updated: 2017-09-27

Results Overview

Systolic blood pressure was measured with an automated monitor. Higher values represent greater systolic pressure. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Recruitment status

COMPLETED

Study phase

EARLY_PHASE1

Target enrollment

11 participants

Primary outcome timeframe

This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Results posted on

2017-09-27

Participant Flow

Eleven subjects were enrolled (i.e., signed consent), but only 10 subjects completed. Due to the within-subject nature of this study (i.e., missing data from the 11th subject cannot be analyzed with repeated-measures ANOVA), only data from the 10 subjects who completed the protocol were analyzed and reported.

Participant milestones

Participant milestones
Measure
Phendimetrazine Dose Escalation
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Intranasal cocaine (10, 20, 40 and 80 mg) was administered acutely after at least seven days of maintenance on each condition. Intransasal placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo were determined during maintenance on placebo and phendimetrazine.
Overall Study
STARTED
11
Overall Study
0 mg Cocaine With 0 mg Phendimetrazine
11
Overall Study
10 mg Cocaine With 0 mg Phendimetrazine
11
Overall Study
20 mg Cocaine With 0 mg Phendimetrazine
10
Overall Study
40 mg Cocaine With 0 mg Phendimetrazine
10
Overall Study
80 mg Cocaine With 0 mg Phendimetrazine
10
Overall Study
0 mg Cocaine With 70 mg Phendimetrazine
10
Overall Study
10 mg Cocaine With 70 mg Phendimetrazine
10
Overall Study
20 mg Cocaine With 70 mg Phendimetrazine
10
Overall Study
40 mg Cocaine With 70 mg Phendimetrazine
10
Overall Study
80 mg Cocaine With 70 mg Phendimetrazine
10
Overall Study
0 mg Cocaine With 140 mg Phendimetrazine
10
Overall Study
10 mg Cocaine with140 mg Phendimetrazine
10
Overall Study
20 mg Cocaine with140 mg Phendimetrazine
10
Overall Study
40 mg Cocaine with140 mg Phendimetrazine
10
Overall Study
80 mg Cocaine with140 mg Phendimetrazine
10
Overall Study
0 mg Cocaine With 210 mg Phendimetrazine
10
Overall Study
10 mg Cocaine with210 mg Phendimetrazine
10
Overall Study
20 mg Cocaine with210 mg Phendimetrazine
10
Overall Study
40 mg Cocaine with210 mg Phendimetrazine
10
Overall Study
80 mg Cocaine with210 mg Phendimetrazine
10
Overall Study
COMPLETED
10
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Phendimetrazine Dose Escalation
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Intranasal cocaine (10, 20, 40 and 80 mg) was administered acutely after at least seven days of maintenance on each condition. Intransasal placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo were determined during maintenance on placebo and phendimetrazine.
Overall Study
Adverse Event
1

Baseline Characteristics

Phendimetrazine and Cocaine

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Age, Continuous
43 years
STANDARD_DEVIATION 4 • n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
6 Participants
n=5 Participants
Race (NIH/OMB)
White
4 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
10 participants
n=5 Participants

PRIMARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Systolic blood pressure was measured with an automated monitor. Higher values represent greater systolic pressure. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Systolic Pressure
0 mg Cocaine with 140 mg Phendimetrazine
117.9 mm Hg
Standard Error 4.78
Peak Systolic Pressure
0 mg Cocaine with 0 mg Phendimetrazine
115.4 mm Hg
Standard Error 2.54
Peak Systolic Pressure
10 mg Cocaine with 0 mg Phendimetrazine
121.3 mm Hg
Standard Error 3.51
Peak Systolic Pressure
20 mg Cocaine with 0 mg Phendimetrazine
123.4 mm Hg
Standard Error 4.06
Peak Systolic Pressure
40 mg Cocaine with 0 mg Phendimetrazine
122.1 mm Hg
Standard Error 2.86
Peak Systolic Pressure
80 mg Cocaine with 0 mg Phendimetrazine
135.4 mm Hg
Standard Error 3.89
Peak Systolic Pressure
0 mg Cocaine with 70 mg Phendimetrazine
120.0 mm Hg
Standard Error 7.14
Peak Systolic Pressure
10 mg Cocaine with 70 mg Phendimetrazine
119.7 mm Hg
Standard Error 3.54
Peak Systolic Pressure
20 mg Cocaine with 70 mg Phendimetrazine
119.9 mm Hg
Standard Error 3.8
Peak Systolic Pressure
40 mg Cocaine with 70 mg Phendimetrazine
125.4 mm Hg
Standard Error 6.05
Peak Systolic Pressure
80 mg Cocaine with 70 mg Phendimetrazine
130.3 mm Hg
Standard Error 2.9
Peak Systolic Pressure
10 mg Cocaine with 140 mg Phendimetrazine
121.7 mm Hg
Standard Error 4.73
Peak Systolic Pressure
20 mg Cocaine with 140 mg Phendimetrazine
122.1 mm Hg
Standard Error 4.4
Peak Systolic Pressure
40 mg Cocaine with 140 mg Phendimetrazine
121.5 mm Hg
Standard Error 4.51
Peak Systolic Pressure
80 mg Cocaine with 140 mg Phendimetrazine
131.9 mm Hg
Standard Error 3.6
Peak Systolic Pressure
0 mg Cocaine with 210 mg Phendimetrazine
119.2 mm Hg
Standard Error 3.45
Peak Systolic Pressure
10 mg Cocaine with 210 mg Phendimetrazine
119.7 mm Hg
Standard Error 4.09
Peak Systolic Pressure
20 mg Cocaine with 210 mg Phendimetrazine
119.8 mm Hg
Standard Error 2.65
Peak Systolic Pressure
40 mg Cocaine with 210 mg Phendimetrazine
119.3 mm Hg
Standard Error 2.72
Peak Systolic Pressure
80 mg Cocaine with 210 mg Phendimetrazine
130.9 mm Hg
Standard Error 2.95

PRIMARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Diastolic blood pressure was measured with an automated monitor. Higher values represent greater diastolic pressure. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Diastolic Pressure
10 mg Cocaine with 210 mg Phendimetrazine
77.9 mm Hg
Standard Error 1.99
Peak Diastolic Pressure
0 mg Cocaine with 0 mg Phendimetrazine
75.6 mm Hg
Standard Error 1.28
Peak Diastolic Pressure
10 mg Cocaine with 0 mg Phendimetrazine
75.2 mm Hg
Standard Error 1.63
Peak Diastolic Pressure
20 mg Cocaine with 0 mg Phendimetrazine
78.4 mm Hg
Standard Error 1.88
Peak Diastolic Pressure
40 mg Cocaine with 0 mg Phendimetrazine
78 mm Hg
Standard Error 1.38
Peak Diastolic Pressure
80 mg Cocaine with 0 mg Phendimetrazine
80.8 mm Hg
Standard Error 1.87
Peak Diastolic Pressure
0 mg Cocaine with 70 mg Phendimetrazine
77.2 mm Hg
Standard Error 2.7
Peak Diastolic Pressure
10 mg Cocaine with 70 mg Phendimetrazine
76.7 mm Hg
Standard Error 2.62
Peak Diastolic Pressure
20 mg Cocaine with 70 mg Phendimetrazine
75.6 mm Hg
Standard Error 2.45
Peak Diastolic Pressure
40 mg Cocaine with 70 mg Phendimetrazine
75.6 mm Hg
Standard Error 3.02
Peak Diastolic Pressure
80 mg Cocaine with 70 mg Phendimetrazine
83.2 mm Hg
Standard Error 2.69
Peak Diastolic Pressure
0 mg Cocaine with 140 mg Phendimetrazine
74.3 mm Hg
Standard Error 1.72
Peak Diastolic Pressure
10 mg Cocaine with 140 mg Phendimetrazine
76 mm Hg
Standard Error 1.84
Peak Diastolic Pressure
20 mg Cocaine with 140 mg Phendimetrazine
78.1 mm Hg
Standard Error 1.29
Peak Diastolic Pressure
40 mg Cocaine with 140 mg Phendimetrazine
77.7 mm Hg
Standard Error 2.28
Peak Diastolic Pressure
80 mg Cocaine with 140 mg Phendimetrazine
83.6 mm Hg
Standard Error 1.26
Peak Diastolic Pressure
0 mg Cocaine with 210 mg Phendimetrazine
76.6 mm Hg
Standard Error 2.42
Peak Diastolic Pressure
20 mg Cocaine with 210 mg Phendimetrazine
80.7 mm Hg
Standard Error 2.34
Peak Diastolic Pressure
40 mg Cocaine with 210 mg Phendimetrazine
78.6 mm Hg
Standard Error 1.83
Peak Diastolic Pressure
80 mg Cocaine with 210 mg Phendimetrazine
84.8 mm Hg
Standard Error 2.37

PRIMARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Heart rate was measured with an automated monitor. Higher values represent greater heart rate. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Heart Rate
40 mg Cocaine with 210 mg Phendimetrazine
82.8 Beats per Minute
Standard Error 3.08
Peak Heart Rate
0 mg Cocaine with 0 mg Phendimetrazine
75 Beats per Minute
Standard Error 3.72
Peak Heart Rate
10 mg Cocaine with 0 mg Phendimetrazine
72.7 Beats per Minute
Standard Error 2.64
Peak Heart Rate
20 mg Cocaine with 0 mg Phendimetrazine
77.4 Beats per Minute
Standard Error 4.19
Peak Heart Rate
40 mg Cocaine with 0 mg Phendimetrazine
79.2 Beats per Minute
Standard Error 4.63
Peak Heart Rate
80 mg Cocaine with 0 mg Phendimetrazine
87.8 Beats per Minute
Standard Error 5.6
Peak Heart Rate
0 mg Cocaine with 70 mg Phendimetrazine
76.6 Beats per Minute
Standard Error 2.57
Peak Heart Rate
10 mg Cocaine with 70 mg Phendimetrazine
75.3 Beats per Minute
Standard Error 3.21
Peak Heart Rate
20 mg Cocaine with 70 mg Phendimetrazine
77 Beats per Minute
Standard Error 3.06
Peak Heart Rate
40 mg Cocaine with 70 mg Phendimetrazine
81 Beats per Minute
Standard Error 4.48
Peak Heart Rate
80 mg Cocaine with 70 mg Phendimetrazine
83.8 Beats per Minute
Standard Error 3.92
Peak Heart Rate
0 mg Cocaine with 140 mg Phendimetrazine
82.1 Beats per Minute
Standard Error 4.07
Peak Heart Rate
10 mg Cocaine with 140 mg Phendimetrazine
81.1 Beats per Minute
Standard Error 3.87
Peak Heart Rate
20 mg Cocaine with 140 mg Phendimetrazine
83.4 Beats per Minute
Standard Error 4.81
Peak Heart Rate
40 mg Cocaine with 140 mg Phendimetrazine
83.5 Beats per Minute
Standard Error 3.66
Peak Heart Rate
80 mg Cocaine with 140 mg Phendimetrazine
84.8 Beats per Minute
Standard Error 4.03
Peak Heart Rate
0 mg Cocaine with 210 mg Phendimetrazine
84.9 Beats per Minute
Standard Error 2.28
Peak Heart Rate
10 mg Cocaine with 210 mg Phendimetrazine
77.5 Beats per Minute
Standard Error 2.2
Peak Heart Rate
20 mg Cocaine with 210 mg Phendimetrazine
85.3 Beats per Minute
Standard Error 4.05
Peak Heart Rate
80 mg Cocaine with 210 mg Phendimetrazine
88.9 Beats per Minute
Standard Error 4.13

PRIMARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Oral temperature was measured with an automated monitor. Higher values represent greater temperature. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Temperature
0 mg Cocaine with 70 mg Phendimetrazine
98.25 Degrees Fahrenheit
Standard Error .07
Peak Temperature
0 mg Cocaine with 140 mg Phendimetrazine
98.19 Degrees Fahrenheit
Standard Error .04
Peak Temperature
10 mg Cocaine with 140 mg Phendimetrazine
98.17 Degrees Fahrenheit
Standard Error .06
Peak Temperature
0 mg Cocaine with 0 mg Phendimetrazine
98.09 Degrees Fahrenheit
Standard Error .13
Peak Temperature
10 mg Cocaine with 0 mg Phendimetrazine
98.12 Degrees Fahrenheit
Standard Error .17
Peak Temperature
20 mg Cocaine with 0 mg Phendimetrazine
98.24 Degrees Fahrenheit
Standard Error .12
Peak Temperature
40 mg Cocaine with 0 mg Phendimetrazine
98.21 Degrees Fahrenheit
Standard Error .15
Peak Temperature
80 mg Cocaine with 0 mg Phendimetrazine
98.04 Degrees Fahrenheit
Standard Error .29
Peak Temperature
10 mg Cocaine with 70 mg Phendimetrazine
98.28 Degrees Fahrenheit
Standard Error .08
Peak Temperature
20 mg Cocaine with 70 mg Phendimetrazine
98.25 Degrees Fahrenheit
Standard Error .12
Peak Temperature
40 mg Cocaine with 70 mg Phendimetrazine
98.24 Degrees Fahrenheit
Standard Error .22
Peak Temperature
80 mg Cocaine with 70 mg Phendimetrazine
98.32 Degrees Fahrenheit
Standard Error .17
Peak Temperature
20 mg Cocaine with 140 mg Phendimetrazine
98.25 Degrees Fahrenheit
Standard Error .05
Peak Temperature
40 mg Cocaine with 140 mg Phendimetrazine
98.2 Degrees Fahrenheit
Standard Error .09
Peak Temperature
80 mg Cocaine with 140 mg Phendimetrazine
98.3 Degrees Fahrenheit
Standard Error .04
Peak Temperature
0 mg Cocaine with 210 mg Phendimetrazine
98.41 Degrees Fahrenheit
Standard Error .07
Peak Temperature
10 mg Cocaine with 210 mg Phendimetrazine
98.17 Degrees Fahrenheit
Standard Error .06
Peak Temperature
20 mg Cocaine with 210 mg Phendimetrazine
98.18 Degrees Fahrenheit
Standard Error .08
Peak Temperature
40 mg Cocaine with 210 mg Phendimetrazine
98.24 Degrees Fahrenheit
Standard Error .07
Peak Temperature
80 mg Cocaine with 210 mg Phendimetrazine
98.38 Degrees Fahrenheit
Standard Error .1

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects completed 16 items that loaded into the Sedative Subscale of the Adjective Rating Scale. The items were rated 0-4 on a Likert-type scale and the sum for the 16 "sedative" items was summed to yield the Sedative Subscale score. The maximum score for this scale was 64, the minimum was 0. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Score on Sedative Subscale of the Adjective Rating Scale
10 mg Cocaine with 0 mg Phendimetrazine
2.5 units on a scale
Standard Error .96
Peak Score on Sedative Subscale of the Adjective Rating Scale
80 mg Cocaine with 210 mg Phendimetrazine
4.7 units on a scale
Standard Error 2.26
Peak Score on Sedative Subscale of the Adjective Rating Scale
0 mg Cocaine with 0 mg Phendimetrazine
2.3 units on a scale
Standard Error .68
Peak Score on Sedative Subscale of the Adjective Rating Scale
20 mg Cocaine with 0 mg Phendimetrazine
2.5 units on a scale
Standard Error .99
Peak Score on Sedative Subscale of the Adjective Rating Scale
40 mg Cocaine with 0 mg Phendimetrazine
2.4 units on a scale
Standard Error .82
Peak Score on Sedative Subscale of the Adjective Rating Scale
80 mg Cocaine with 0 mg Phendimetrazine
4.4 units on a scale
Standard Error 1.54
Peak Score on Sedative Subscale of the Adjective Rating Scale
0 mg Cocaine with 70 mg Phendimetrazine
1.9 units on a scale
Standard Error .59
Peak Score on Sedative Subscale of the Adjective Rating Scale
10 mg Cocaine with 70 mg Phendimetrazine
2.2 units on a scale
Standard Error 1.03
Peak Score on Sedative Subscale of the Adjective Rating Scale
20 mg Cocaine with 70 mg Phendimetrazine
3.5 units on a scale
Standard Error 1.65
Peak Score on Sedative Subscale of the Adjective Rating Scale
40 mg Cocaine with 70 mg Phendimetrazine
4.2 units on a scale
Standard Error 2.27
Peak Score on Sedative Subscale of the Adjective Rating Scale
80 mg Cocaine with 70 mg Phendimetrazine
4.2 units on a scale
Standard Error 2.06
Peak Score on Sedative Subscale of the Adjective Rating Scale
0 mg Cocaine with 140 mg Phendimetrazine
2.1 units on a scale
Standard Error 1.22
Peak Score on Sedative Subscale of the Adjective Rating Scale
10 mg Cocaine with 140 mg Phendimetrazine
2.7 units on a scale
Standard Error 1.56
Peak Score on Sedative Subscale of the Adjective Rating Scale
20 mg Cocaine with 140 mg Phendimetrazine
3.1 units on a scale
Standard Error 1.62
Peak Score on Sedative Subscale of the Adjective Rating Scale
40 mg Cocaine with 140 mg Phendimetrazine
2.8 units on a scale
Standard Error 1.52
Peak Score on Sedative Subscale of the Adjective Rating Scale
80 mg Cocaine with 140 mg Phendimetrazine
4.0 units on a scale
Standard Error 2.19
Peak Score on Sedative Subscale of the Adjective Rating Scale
0 mg Cocaine with 210 mg Phendimetrazine
1.8 units on a scale
Standard Error .57
Peak Score on Sedative Subscale of the Adjective Rating Scale
10 mg Cocaine with 210 mg Phendimetrazine
2.6 units on a scale
Standard Error .9
Peak Score on Sedative Subscale of the Adjective Rating Scale
20 mg Cocaine with 210 mg Phendimetrazine
3.8 units on a scale
Standard Error 1.4
Peak Score on Sedative Subscale of the Adjective Rating Scale
40 mg Cocaine with 210 mg Phendimetrazine
4.2 units on a scale
Standard Error 1.68

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects completed 16 items that loaded into the Stimulant Subscale of the Adjective Rating Scale. The items were rated 0-4 on a Likert-type scale and the sum for the 16 "stimulant" items was summed to yield the Stimulant Subscale score. The maximum score for this scale was 64, the minimum was 0. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Score on Stimulant Subscale of the Adjective Rating Scale
20 mg Cocaine with 0 mg Phendimetrazine
6.3 units on a scale
Standard Error 1.52
Peak Score on Stimulant Subscale of the Adjective Rating Scale
0 mg Cocaine with 0 mg Phendimetrazine
5.2 units on a scale
Standard Error 1.05
Peak Score on Stimulant Subscale of the Adjective Rating Scale
10 mg Cocaine with 0 mg Phendimetrazine
5.5 units on a scale
Standard Error 1.33
Peak Score on Stimulant Subscale of the Adjective Rating Scale
40 mg Cocaine with 0 mg Phendimetrazine
6.6 units on a scale
Standard Error 1.64
Peak Score on Stimulant Subscale of the Adjective Rating Scale
80 mg Cocaine with 0 mg Phendimetrazine
8.1 units on a scale
Standard Error 1.47
Peak Score on Stimulant Subscale of the Adjective Rating Scale
0 mg Cocaine with 70 mg Phendimetrazine
4.4 units on a scale
Standard Error .97
Peak Score on Stimulant Subscale of the Adjective Rating Scale
10 mg Cocaine with 70 mg Phendimetrazine
5.2 units on a scale
Standard Error .92
Peak Score on Stimulant Subscale of the Adjective Rating Scale
20 mg Cocaine with 70 mg Phendimetrazine
6.3 units on a scale
Standard Error 1.17
Peak Score on Stimulant Subscale of the Adjective Rating Scale
40 mg Cocaine with 70 mg Phendimetrazine
6.2 units on a scale
Standard Error .9
Peak Score on Stimulant Subscale of the Adjective Rating Scale
80 mg Cocaine with 70 mg Phendimetrazine
7.3 units on a scale
Standard Error 1.26
Peak Score on Stimulant Subscale of the Adjective Rating Scale
0 mg Cocaine with 140 mg Phendimetrazine
3.7 units on a scale
Standard Error 1.10
Peak Score on Stimulant Subscale of the Adjective Rating Scale
10 mg Cocaine with 140 mg Phendimetrazine
5.3 units on a scale
Standard Error .91
Peak Score on Stimulant Subscale of the Adjective Rating Scale
20 mg Cocaine with 140 mg Phendimetrazine
5.8 units on a scale
Standard Error 1.18
Peak Score on Stimulant Subscale of the Adjective Rating Scale
40 mg Cocaine with 140 mg Phendimetrazine
7.8 units on a scale
Standard Error 1.54
Peak Score on Stimulant Subscale of the Adjective Rating Scale
80 mg Cocaine with 140 mg Phendimetrazine
8.1 units on a scale
Standard Error 1.43
Peak Score on Stimulant Subscale of the Adjective Rating Scale
0 mg Cocaine with 210 mg Phendimetrazine
4.7 units on a scale
Standard Error 1.08
Peak Score on Stimulant Subscale of the Adjective Rating Scale
10 mg Cocaine with 210 mg Phendimetrazine
5.2 units on a scale
Standard Error 1.14
Peak Score on Stimulant Subscale of the Adjective Rating Scale
20 mg Cocaine with 210 mg Phendimetrazine
7.4 units on a scale
Standard Error 1.38
Peak Score on Stimulant Subscale of the Adjective Rating Scale
40 mg Cocaine with 210 mg Phendimetrazine
7.3 units on a scale
Standard Error 1.35
Peak Score on Stimulant Subscale of the Adjective Rating Scale
80 mg Cocaine with 210 mg Phendimetrazine
9 units on a scale
Standard Error 1.23

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Active, Alert, Energetic" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.6 units on a scale
Standard Error .5
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
3.9 units on a scale
Standard Error 1.91
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
8.9 units on a scale
Standard Error 3.89
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
7.8 units on a scale
Standard Error 4.99
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
14 units on a scale
Standard Error 6.23
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
1.5 units on a scale
Standard Error 1
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
6 units on a scale
Standard Error 2.28
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
9 units on a scale
Standard Error 3.87
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
13.4 units on a scale
Standard Error 3.91
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
16 units on a scale
Standard Error 4.17
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.7 units on a scale
Standard Error .6
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
4 units on a scale
Standard Error 1.76
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
11.4 units on a scale
Standard Error 4.7
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
14.8 units on a scale
Standard Error 4.7
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
18.9 units on a scale
Standard Error 5.31
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
1 units on a scale
Standard Error .89
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
1.8 units on a scale
Standard Error .85
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
10.1 units on a scale
Standard Error 3.71
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
11.1 units on a scale
Standard Error 3.89
Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
17 units on a scale
Standard Error 5.8

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Any Effect" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Any Effect" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
12.8 units on a scale
Standard Error 3.59
Peak Ratings of "Any Effect" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
28.1 units on a scale
Standard Error 4.86
Peak Ratings of "Any Effect" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
4.6 units on a scale
Standard Error 2.74
Peak Ratings of "Any Effect" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
27.3 units on a scale
Standard Error 7.81
Peak Ratings of "Any Effect" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.5 units on a scale
Standard Error .5
Peak Ratings of "Any Effect" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
7 units on a scale
Standard Error 1.99
Peak Ratings of "Any Effect" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
19 units on a scale
Standard Error 4.96
Peak Ratings of "Any Effect" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
10.5 units on a scale
Standard Error 3.37
Peak Ratings of "Any Effect" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
14.7 units on a scale
Standard Error 4.33
Peak Ratings of "Any Effect" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1.5 units on a scale
Standard Error .83
Peak Ratings of "Any Effect" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
4.7 units on a scale
Standard Error 1.57
Peak Ratings of "Any Effect" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
13.2 units on a scale
Standard Error 4.93
Peak Ratings of "Any Effect" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
16.9 units on a scale
Standard Error 4.32
Peak Ratings of "Any Effect" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
26 units on a scale
Standard Error 6.53
Peak Ratings of "Any Effect" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.9 units on a scale
Standard Error .64
Peak Ratings of "Any Effect" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
7.7 units on a scale
Standard Error 2.59
Peak Ratings of "Any Effect" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
13.5 units on a scale
Standard Error 4.84
Peak Ratings of "Any Effect" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
21.2 units on a scale
Standard Error 6.9
Peak Ratings of "Any Effect" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
21.5 units on a scale
Standard Error 4.25
Peak Ratings of "Any Effect" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
35.1 units on a scale
Standard Error 7.54

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Bad Effect" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Bad Effect" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
11.4 units on a scale
Standard Error 5.39
Peak Ratings of "Bad Effect" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.6 units on a scale
Standard Error .4
Peak Ratings of "Bad Effect" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
2.1 units on a scale
Standard Error 1.3
Peak Ratings of "Bad Effect" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
4.9 units on a scale
Standard Error 3.52
Peak Ratings of "Bad Effect" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
6.6 units on a scale
Standard Error 4.04
Peak Ratings of "Bad Effect" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
8.5 units on a scale
Standard Error 4.74
Peak Ratings of "Bad Effect" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
1.3 units on a scale
Standard Error .87
Peak Ratings of "Bad Effect" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
2 units on a scale
Standard Error 1.42
Peak Ratings of "Bad Effect" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
5.6 units on a scale
Standard Error 2.4
Peak Ratings of "Bad Effect" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
4.9 units on a scale
Standard Error 2.70
Peak Ratings of "Bad Effect" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
5.6 units on a scale
Standard Error 3.73
Peak Ratings of "Bad Effect" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.7 units on a scale
Standard Error .7
Peak Ratings of "Bad Effect" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
1.9 units on a scale
Standard Error 1.33
Peak Ratings of "Bad Effect" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
5.7 units on a scale
Standard Error 3.14
Peak Ratings of "Bad Effect" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
3.7 units on a scale
Standard Error 2.63
Peak Ratings of "Bad Effect" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
9.2 units on a scale
Standard Error 7.77
Peak Ratings of "Bad Effect" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
2.4 units on a scale
Standard Error 1.52
Peak Ratings of "Bad Effect" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
3.9 units on a scale
Standard Error 2.17
Peak Ratings of "Bad Effect" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
8.1 units on a scale
Standard Error 4.45
Peak Ratings of "Bad Effect" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
10.2 units on a scale
Standard Error 7.23

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Euphoric" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Euphoric" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1 units on a scale
Standard Error .89
Peak Ratings of "Euphoric" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
1.8 units on a scale
Standard Error .87
Peak Ratings of "Euphoric" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
3.1 units on a scale
Standard Error 1.87
Peak Ratings of "Euphoric" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
1.2 units on a scale
Standard Error .81
Peak Ratings of "Euphoric" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
1.9 units on a scale
Standard Error 1.32
Peak Ratings of "Euphoric" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
1 units on a scale
Standard Error .6
Peak Ratings of "Euphoric" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
1 units on a scale
Standard Error .52
Peak Ratings of "Euphoric" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
3.2 units on a scale
Standard Error 1.52
Peak Ratings of "Euphoric" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
1.2 units on a scale
Standard Error .63
Peak Ratings of "Euphoric" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
2 units on a scale
Standard Error 1
Peak Ratings of "Euphoric" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.9 units on a scale
Standard Error .64
Peak Ratings of "Euphoric" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
2 units on a scale
Standard Error 1.16
Peak Ratings of "Euphoric" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
1.3 units on a scale
Standard Error .7
Peak Ratings of "Euphoric" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
1 units on a scale
Standard Error .54
Peak Ratings of "Euphoric" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
1.3 units on a scale
Standard Error .7
Peak Ratings of "Euphoric" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
.9 units on a scale
Standard Error .48
Peak Ratings of "Euphoric" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
.4 units on a scale
Standard Error .4
Peak Ratings of "Euphoric" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
1 units on a scale
Standard Error .68
Peak Ratings of "Euphoric" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
.8 units on a scale
Standard Error .47
Peak Ratings of "Euphoric" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
1.7 units on a scale
Standard Error .82

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Good Effect" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Good Effect" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1.2 units on a scale
Standard Error .73
Peak Ratings of "Good Effect" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
7.1 units on a scale
Standard Error 2.74
Peak Ratings of "Good Effect" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
12.4 units on a scale
Standard Error 4.61
Peak Ratings of "Good Effect" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
12.3 units on a scale
Standard Error 5.27
Peak Ratings of "Good Effect" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
19.8 units on a scale
Standard Error 7.01
Peak Ratings of "Good Effect" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
1.3 units on a scale
Standard Error .94
Peak Ratings of "Good Effect" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
7.1 units on a scale
Standard Error 2.48
Peak Ratings of "Good Effect" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
11.7 units on a scale
Standard Error 3.77
Peak Ratings of "Good Effect" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
15.3 units on a scale
Standard Error 5.14
Peak Ratings of "Good Effect" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
21.3 units on a scale
Standard Error 5.57
Peak Ratings of "Good Effect" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
2.1 units on a scale
Standard Error 1.13
Peak Ratings of "Good Effect" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
8.1 units on a scale
Standard Error 2.67
Peak Ratings of "Good Effect" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
7.9 units on a scale
Standard Error 3.9
Peak Ratings of "Good Effect" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
15.4 units on a scale
Standard Error 5.39
Peak Ratings of "Good Effect" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
27.8 units on a scale
Standard Error 6.5
Peak Ratings of "Good Effect" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
9.2 units on a scale
Standard Error 7.77
Peak Ratings of "Good Effect" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
12 units on a scale
Standard Error 4.51
Peak Ratings of "Good Effect" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
16.7 units on a scale
Standard Error 6.33
Peak Ratings of "Good Effect" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
17.1 units on a scale
Standard Error 4.33
Peak Ratings of "Good Effect" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
27.2 units on a scale
Standard Error 7.56

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "High" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "High" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
23.4 units on a scale
Standard Error 6.42
Peak Ratings of "High" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
6.3 units on a scale
Standard Error 2.96
Peak Ratings of "High" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1.4 units on a scale
Standard Error .69
Peak Ratings of "High" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
6 units on a scale
Standard Error 2.29
Peak Ratings of "High" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
14.1 units on a scale
Standard Error 4.9
Peak Ratings of "High" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
11.9 units on a scale
Standard Error 4.81
Peak Ratings of "High" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
1.1 units on a scale
Standard Error .6
Peak Ratings of "High" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
3.6 units on a scale
Standard Error 1.18
Peak Ratings of "High" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
10.8 units on a scale
Standard Error 4.14
Peak Ratings of "High" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
13.3 units on a scale
Standard Error 5.55
Peak Ratings of "High" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
18.6 units on a scale
Standard Error 6.52
Peak Ratings of "High" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.6 units on a scale
Standard Error .5
Peak Ratings of "High" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
9.1 units on a scale
Standard Error 4.39
Peak Ratings of "High" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
15.8 units on a scale
Standard Error 5.96
Peak Ratings of "High" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
24.2 units on a scale
Standard Error 6.77
Peak Ratings of "High" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
.8 units on a scale
Standard Error .59
Peak Ratings of "High" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
8.3 units on a scale
Standard Error 4.14
Peak Ratings of "High" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
15.3 units on a scale
Standard Error 6.35
Peak Ratings of "High" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
12.1 units on a scale
Standard Error 3.14
Peak Ratings of "High" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
22.6 units on a scale
Standard Error 7.05

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Irregular/Racing Heartbeat" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
6.9 units on a scale
Standard Error 3.7
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
2.3 units on a scale
Standard Error 1.21
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.8 units on a scale
Standard Error .51
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
2.8 units on a scale
Standard Error 1.19
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
10.8 units on a scale
Standard Error 4.07
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
9.2 units on a scale
Standard Error 5
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
14.6 units on a scale
Standard Error 7
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.4 units on a scale
Standard Error .4
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
1.6 units on a scale
Standard Error .6
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
2.4 units on a scale
Standard Error 1.3
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
6 units on a scale
Standard Error 2.9
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.6 units on a scale
Standard Error .4
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
.8 units on a scale
Standard Error .55
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
3.6 units on a scale
Standard Error 2.56
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
5.10 units on a scale
Standard Error 2.15
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
8.2 units on a scale
Standard Error 4.17
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
.6 units on a scale
Standard Error .5
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
4 units on a scale
Standard Error 3.36
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
5.5 units on a scale
Standard Error 3.48
Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
9.8 units on a scale
Standard Error 4.85

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Like Drug" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Like Drug" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1 units on a scale
Standard Error .54
Peak Ratings of "Like Drug" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
6.4 units on a scale
Standard Error 2.01
Peak Ratings of "Like Drug" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
12.9 units on a scale
Standard Error 4.58
Peak Ratings of "Like Drug" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
14 units on a scale
Standard Error 5.82
Peak Ratings of "Like Drug" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
23.2 units on a scale
Standard Error 8.32
Peak Ratings of "Like Drug" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.5 units on a scale
Standard Error .5
Peak Ratings of "Like Drug" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
4.1 units on a scale
Standard Error 1.49
Peak Ratings of "Like Drug" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
10.7 units on a scale
Standard Error 3.52
Peak Ratings of "Like Drug" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
17.9 units on a scale
Standard Error 5.13
Peak Ratings of "Like Drug" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
25 units on a scale
Standard Error 6.93
Peak Ratings of "Like Drug" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
1.2 units on a scale
Standard Error .8
Peak Ratings of "Like Drug" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
9.8 units on a scale
Standard Error 3.16
Peak Ratings of "Like Drug" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
9.9 units on a scale
Standard Error 3.93
Peak Ratings of "Like Drug" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
18 units on a scale
Standard Error 6.01
Peak Ratings of "Like Drug" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
26.2 units on a scale
Standard Error 6.32
Peak Ratings of "Like Drug" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
2.2 units on a scale
Standard Error 1.44
Peak Ratings of "Like Drug" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
7.5 units on a scale
Standard Error 2.66
Peak Ratings of "Like Drug" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
13.1 units on a scale
Standard Error 4.72
Peak Ratings of "Like Drug" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
25.5 units on a scale
Standard Error 9.3
Peak Ratings of "Like Drug" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
26.5 units on a scale
Standard Error 8.32

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Nauseated/Queasy/Sick to Stomach" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
1.7 units on a scale
Standard Error 1.25
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
4.8 units on a scale
Standard Error 2.83
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1.4 units on a scale
Standard Error .69
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
3.3 units on a scale
Standard Error 1.54
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
3.1 units on a scale
Standard Error 1.29
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
7.8 units on a scale
Standard Error 2.59
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
14 units on a scale
Standard Error 5.79
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.6 units on a scale
Standard Error .43
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
4.3 units on a scale
Standard Error 2.32
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
4.3 units on a scale
Standard Error 2.17
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
5.3 units on a scale
Standard Error 4.22
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
10.5 units on a scale
Standard Error 5.45
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.6 units on a scale
Standard Error .5
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
4.1 units on a scale
Standard Error 2.77
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
2.9 units on a scale
Standard Error 1.96
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
6.9 units on a scale
Standard Error 3.59
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
10.7 units on a scale
Standard Error 5.7
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
5.2 units on a scale
Standard Error 4.14
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
4.3 units on a scale
Standard Error 2.54
Peak Ratings of "Nauseated/Queasy/Sick to Stomach" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
2.9 units on a scale
Standard Error 1.89

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Nervous/Anxious" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
9.4 units on a scale
Standard Error 6
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.7 units on a scale
Standard Error .47
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
2.3 units on a scale
Standard Error 1.12
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
3.7 units on a scale
Standard Error 2.27
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
4.1 units on a scale
Standard Error 2.61
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.6 units on a scale
Standard Error .43
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
.9 units on a scale
Standard Error .53
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
2 units on a scale
Standard Error 1.14
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
5.4 units on a scale
Standard Error 2.50
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
7.7 units on a scale
Standard Error 4.46
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.5 units on a scale
Standard Error .4
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
1.7 units on a scale
Standard Error .75
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
2.5 units on a scale
Standard Error 1.24
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
6.7 units on a scale
Standard Error 2.96
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
10.5 units on a scale
Standard Error 4.22
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
.8 units on a scale
Standard Error .55
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
.5 units on a scale
Standard Error .4
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
3.7 units on a scale
Standard Error 2.13
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
4.4 units on a scale
Standard Error 2.28
Peak Ratings of "Nervous/Anxious" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
10.1 units on a scale
Standard Error 6.52

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Willing to Pay For" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.9 units on a scale
Standard Error .9
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
4.4 units on a scale
Standard Error 2.49
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
8.2 units on a scale
Standard Error 3.53
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
11.2 units on a scale
Standard Error 4.59
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
20.2 units on a scale
Standard Error 7.01
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
1.1 units on a scale
Standard Error .72
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
1.4 units on a scale
Standard Error .86
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
6.4 units on a scale
Standard Error 2.9
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
14.1 units on a scale
Standard Error 4.62
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
19.3 units on a scale
Standard Error 5.63
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.8 units on a scale
Standard Error .42
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
3.2 units on a scale
Standard Error 2.15
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
7.9 units on a scale
Standard Error 3.82
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
18.3 units on a scale
Standard Error 6.58
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
23 units on a scale
Standard Error 5.77
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
1.7 units on a scale
Standard Error 1.32
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
6 units on a scale
Standard Error 2.65
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
8.9 units on a scale
Standard Error 4.39
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
12.3 units on a scale
Standard Error 3.77
Peak Ratings of "Willing to Pay For" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
23.1 units on a scale
Standard Error 9.27

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Performance Impaired" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
7.6 units on a scale
Standard Error 5.07
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.8 units on a scale
Standard Error .7
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
.7 units on a scale
Standard Error .47
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
1.9 units on a scale
Standard Error .98
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
3.3 units on a scale
Standard Error 1.24
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
3.4 units on a scale
Standard Error 1.31
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
1 units on a scale
Standard Error .68
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
2.2 units on a scale
Standard Error 1.12
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
.8 units on a scale
Standard Error .55
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
.7 units on a scale
Standard Error .6
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
4.9 units on a scale
Standard Error 2.82
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.8 units on a scale
Standard Error .42
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
.7 units on a scale
Standard Error .47
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
4.5 units on a scale
Standard Error 3.56
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
2.1 units on a scale
Standard Error 1
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
3.7 units on a scale
Standard Error 1.78
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
.8 units on a scale
Standard Error .55
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
.3 units on a scale
Standard Error .3
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
4.4 units on a scale
Standard Error 3.65
Peak Ratings of "Performance Impaired" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
7.6 units on a scale
Standard Error 5.24

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Performance Improved" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Performance Improved" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.7 units on a scale
Standard Error .6
Peak Ratings of "Performance Improved" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
.7 units on a scale
Standard Error .42
Peak Ratings of "Performance Improved" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
1.4 units on a scale
Standard Error .72
Peak Ratings of "Performance Improved" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
1.4 units on a scale
Standard Error .6
Peak Ratings of "Performance Improved" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
6.6 units on a scale
Standard Error 4.49
Peak Ratings of "Performance Improved" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.7 units on a scale
Standard Error .6
Peak Ratings of "Performance Improved" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
.6 units on a scale
Standard Error .5
Peak Ratings of "Performance Improved" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
1.9 units on a scale
Standard Error .91
Peak Ratings of "Performance Improved" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
4.8 units on a scale
Standard Error 3.31
Peak Ratings of "Performance Improved" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
2.4 units on a scale
Standard Error 1.15
Peak Ratings of "Performance Improved" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.9 units on a scale
Standard Error .6
Peak Ratings of "Performance Improved" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
.9 units on a scale
Standard Error .6
Peak Ratings of "Performance Improved" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
.8 units on a scale
Standard Error .61
Peak Ratings of "Performance Improved" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
3.6 units on a scale
Standard Error 2.84
Peak Ratings of "Performance Improved" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
5.1 units on a scale
Standard Error 3.58
Peak Ratings of "Performance Improved" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
1.9 units on a scale
Standard Error 1.29
Peak Ratings of "Performance Improved" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
.5 units on a scale
Standard Error .4
Peak Ratings of "Performance Improved" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
1.6 units on a scale
Standard Error 1.06
Peak Ratings of "Performance Improved" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
3.9 units on a scale
Standard Error 2.9
Peak Ratings of "Performance Improved" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
2.6 units on a scale
Standard Error 1.65

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Restless" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Restless" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.5 units on a scale
Standard Error .4
Peak Ratings of "Restless" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
1.9 units on a scale
Standard Error 1.08
Peak Ratings of "Restless" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
.7 units on a scale
Standard Error .6
Peak Ratings of "Restless" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
1.8 units on a scale
Standard Error 1.01
Peak Ratings of "Restless" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
2.3 units on a scale
Standard Error 1.32
Peak Ratings of "Restless" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.5 units on a scale
Standard Error .5
Peak Ratings of "Restless" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
.9 units on a scale
Standard Error .53
Peak Ratings of "Restless" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
.7 units on a scale
Standard Error .47
Peak Ratings of "Restless" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
1.1 units on a scale
Standard Error .64
Peak Ratings of "Restless" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
1 units on a scale
Standard Error .54
Peak Ratings of "Restless" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
1 units on a scale
Standard Error .68
Peak Ratings of "Restless" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
1.8 units on a scale
Standard Error .9
Peak Ratings of "Restless" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
2.3 units on a scale
Standard Error 1.67
Peak Ratings of "Restless" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
4.1 units on a scale
Standard Error 1.96
Peak Ratings of "Restless" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
4 units on a scale
Standard Error 2.04
Peak Ratings of "Restless" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
1.6 units on a scale
Standard Error .99
Peak Ratings of "Restless" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
2.7 units on a scale
Standard Error 2.28
Peak Ratings of "Restless" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
2.0 units on a scale
Standard Error 1.61
Peak Ratings of "Restless" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
3.6 units on a scale
Standard Error 1.59
Peak Ratings of "Restless" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
6.9 units on a scale
Standard Error 5.38

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Rush" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Rush" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
.5 units on a scale
Standard Error .5
Peak Ratings of "Rush" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
11.1 units on a scale
Standard Error 4.32
Peak Ratings of "Rush" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
5.67 units on a scale
Standard Error 2.12
Peak Ratings of "Rush" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
10.3 units on a scale
Standard Error 3.62
Peak Ratings of "Rush" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
4.4 units on a scale
Standard Error 2.4
Peak Ratings of "Rush" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
11.9 units on a scale
Standard Error 4.53
Peak Ratings of "Rush" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
11.4 units on a scale
Standard Error 5.93
Peak Ratings of "Rush" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
17.4 units on a scale
Standard Error 7.06
Peak Ratings of "Rush" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.9 units on a scale
Standard Error .6
Peak Ratings of "Rush" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
3.4 units on a scale
Standard Error 1.5
Peak Ratings of "Rush" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
8 units on a scale
Standard Error 3.73
Peak Ratings of "Rush" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
20 units on a scale
Standard Error 7.11
Peak Ratings of "Rush" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
1 units on a scale
Standard Error .67
Peak Ratings of "Rush" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
9.2 units on a scale
Standard Error 3.44
Peak Ratings of "Rush" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
16.3 units on a scale
Standard Error 5.95
Peak Ratings of "Rush" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
21.8 units on a scale
Standard Error 6.03
Peak Ratings of "Rush" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
1.4 units on a scale
Standard Error .86
Peak Ratings of "Rush" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
7.3 units on a scale
Standard Error 2.49
Peak Ratings of "Rush" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
13.2 units on a scale
Standard Error 4.55
Peak Ratings of "Rush" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
16.9 units on a scale
Standard Error 5.58

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Shaky/Jittery" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1.7 units on a scale
Standard Error .88
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
1.8 units on a scale
Standard Error .88
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
6.1 units on a scale
Standard Error 3.14
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
6 units on a scale
Standard Error 3.78
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
11.9 units on a scale
Standard Error 7.28
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.4 units on a scale
Standard Error .4
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
.5 units on a scale
Standard Error .5
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
1.8 units on a scale
Standard Error 1.05
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
2.4 units on a scale
Standard Error 1.61
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
6.5 units on a scale
Standard Error 3.39
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
1.4 units on a scale
Standard Error .79
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
.9 units on a scale
Standard Error .6
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
3.8 units on a scale
Standard Error 1.7
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
3.9 units on a scale
Standard Error 2.3
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
12.8 units on a scale
Standard Error 5.33
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
.3 units on a scale
Standard Error .3
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
.8 units on a scale
Standard Error .55
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
1.9 units on a scale
Standard Error 1.04
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
6.6 units on a scale
Standard Error 2.92
Peak Ratings of "Shaky/Jittery" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
9 units on a scale
Standard Error 5.58

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Sluggish/Fatigued/Lazy" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.6 units on a scale
Standard Error .43
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1.7 units on a scale
Standard Error .9
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
1.8 units on a scale
Standard Error 1.09
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
1.09 units on a scale
Standard Error 1
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
3.3 units on a scale
Standard Error 1.81
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
8.5 units on a scale
Standard Error 5.85
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
3.0 units on a scale
Standard Error 1.96
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
3.3 units on a scale
Standard Error 2.47
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
5.3 units on a scale
Standard Error 3.53
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
6 units on a scale
Standard Error 3.53
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
.7 units on a scale
Standard Error .4
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
4.8 units on a scale
Standard Error 2.27
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
4.6 units on a scale
Standard Error 2.47
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
5.3 units on a scale
Standard Error 2.94
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
10.9 units on a scale
Standard Error 5.49
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
7 units on a scale
Standard Error 5.82
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
5.5 units on a scale
Standard Error 2.67
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
4.8 units on a scale
Standard Error 2.64
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
4.2 units on a scale
Standard Error 2.63
Peak Ratings of "Sluggish/Fatigued/Lazy" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
8.8 units on a scale
Standard Error 7.16

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Stimulated" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Stimulated" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
2 units on a scale
Standard Error .93
Peak Ratings of "Stimulated" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
5.6 units on a scale
Standard Error 2.9
Peak Ratings of "Stimulated" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1.8 units on a scale
Standard Error .8
Peak Ratings of "Stimulated" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
5.1 units on a scale
Standard Error 2.56
Peak Ratings of "Stimulated" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
10.8 units on a scale
Standard Error 4.92
Peak Ratings of "Stimulated" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.8 units on a scale
Standard Error .53
Peak Ratings of "Stimulated" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
3.7 units on a scale
Standard Error 1.55
Peak Ratings of "Stimulated" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
4.9 units on a scale
Standard Error 2.61
Peak Ratings of "Stimulated" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
8.9 units on a scale
Standard Error 4.42
Peak Ratings of "Stimulated" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
12.4 units on a scale
Standard Error 4.53
Peak Ratings of "Stimulated" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
1.6 units on a scale
Standard Error .82
Peak Ratings of "Stimulated" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
2.9 units on a scale
Standard Error 1.28
Peak Ratings of "Stimulated" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
5.5 units on a scale
Standard Error 3.59
Peak Ratings of "Stimulated" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
11.6 units on a scale
Standard Error 5.36
Peak Ratings of "Stimulated" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
10.9 units on a scale
Standard Error 5.12
Peak Ratings of "Stimulated" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
2.2 units on a scale
Standard Error 1.14
Peak Ratings of "Stimulated" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
2.4 units on a scale
Standard Error 1.56
Peak Ratings of "Stimulated" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
4.8 units on a scale
Standard Error 2.45
Peak Ratings of "Stimulated" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
9.1 units on a scale
Standard Error 3.52
Peak Ratings of "Stimulated" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
14.7 units on a scale
Standard Error 6.91

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Willing to Take Again" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1.1 units on a scale
Standard Error .66
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
13 units on a scale
Standard Error 3.86
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
20.7 units on a scale
Standard Error 5.96
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
9.8 units on a scale
Standard Error 5.13
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
14.1 units on a scale
Standard Error 5.44
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
16.5 units on a scale
Standard Error 7.26
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
22.9 units on a scale
Standard Error 8.82
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
1.5 units on a scale
Standard Error .89
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
3.5 units on a scale
Standard Error .96
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
26.7 units on a scale
Standard Error 7.53
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
1 units on a scale
Standard Error .63
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
8.8 units on a scale
Standard Error 4.12
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
11.1 units on a scale
Standard Error 4.8
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
19.4 units on a scale
Standard Error 5.81
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
25.8 units on a scale
Standard Error 5.2
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
2 units on a scale
Standard Error 1.32
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
11.2 units on a scale
Standard Error 5.20
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
11.6 units on a scale
Standard Error 4.69
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
17.9 units on a scale
Standard Error 5.15
Peak Ratings of "Willing to Take Again" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
30 units on a scale
Standard Error 8.78

SECONDARY outcome

Timeframe: This measure was completed at 15 minute intervals after sampling each cocaine dose under both phendimetrazine and placebo maintenance conditions.

Subjects rated their feelings of "Talkative/Friendly" on a Visual Analog Scale. This item was rated from 0 (minimum)-100 (maximum) on a Visual Analog Scale. Higher values represent greater subjective effects on this item. Peak scores were calculated from multiple assessments for each cocaine dose under both phendimetrazine and placebo conditions.

Outcome measures

Outcome measures
Measure
Phendimetrazine Dose Escalation
n=10 Participants
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Cocaine was administered acutely after at least seven days of maintenance on each condition. Placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo cocaine were determined during maintenance on placebo and phendimetrazine.
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
20 mg Cocaine with 140 mg Phendimetrazine
1.9 units on a scale
Standard Error 1.04
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
0 mg Cocaine with 0 mg Phendimetrazine
1 units on a scale
Standard Error .6
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
10 mg Cocaine with 0 mg Phendimetrazine
2.7 units on a scale
Standard Error 1.28
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
20 mg Cocaine with 0 mg Phendimetrazine
3.9 units on a scale
Standard Error 2.96
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
40 mg Cocaine with 0 mg Phendimetrazine
3.5 units on a scale
Standard Error 2.4
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
80 mg Cocaine with 0 mg Phendimetrazine
4.3 units on a scale
Standard Error 2.82
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
0 mg Cocaine with 70 mg Phendimetrazine
.6 units on a scale
Standard Error .6
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
10 mg Cocaine with 70 mg Phendimetrazine
2.7 units on a scale
Standard Error 1.21
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
20 mg Cocaine with 70 mg Phendimetrazine
5.4 units on a scale
Standard Error 2.63
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
40 mg Cocaine with 70 mg Phendimetrazine
7.3 units on a scale
Standard Error 3.09
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
80 mg Cocaine with 70 mg Phendimetrazine
8 units on a scale
Standard Error 3.87
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
0 mg Cocaine with 140 mg Phendimetrazine
1 units on a scale
Standard Error .68
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
10 mg Cocaine with 140 mg Phendimetrazine
1.2 units on a scale
Standard Error .81
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
40 mg Cocaine with 140 mg Phendimetrazine
3.2 units on a scale
Standard Error 1.65
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
80 mg Cocaine with 140 mg Phendimetrazine
7.2 units on a scale
Standard Error 2.74
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
0 mg Cocaine with 210 mg Phendimetrazine
.7 units on a scale
Standard Error .47
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
10 mg Cocaine with 210 mg Phendimetrazine
.5 units on a scale
Standard Error .34
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
20 mg Cocaine with 210 mg Phendimetrazine
1.9 units on a scale
Standard Error .92
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
40 mg Cocaine with 210 mg Phendimetrazine
1.7 units on a scale
Standard Error 1.11
Peak Ratings of "Talkative/Friendly" on the Visual Analog Scale
80 mg Cocaine with 210 mg Phendimetrazine
3.4 units on a scale
Standard Error 1.43

Adverse Events

Phendimetrazine Dose Escalation

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Phendimetrazine Dose Escalation
n=11 participants at risk
Subjects were maintained on oral placebo, 70 mg phendimetrazine/day, 140 mg phendimetrazine/day and 210 mg phendimetrazine/day in ascending order. Intranasal cocaine (10, 20, 40 and 80 mg) was administered acutely after at least seven days of maintenance on each condition. Intransasal placebo cocaine was administered acutely after at least seven days of maintenance on each condition. Cocaine: The pharmacodynamic effects of cocaine were determined during maintenance on placebo and phendimetrazine. Placebo: The pharmacodynamic effects of placebo were determined during maintenance on placebo and phendimetrazine.
Cardiac disorders
Persistent Tachycardia
9.1%
1/11 • Number of events 1

Additional Information

William W. Stoops, Ph.D.

University of Kentucky

Phone: 859-257-5388

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place